Cellumed Co.,Ltd. (KOSDAQ:049180)
1,009.00
-101.00 (-9.10%)
At close: Mar 16, 2026
Cellumed Revenue
In the year 2025, Cellumed had annual revenue of 140.19B KRW with 8.56% growth. Cellumed had revenue of 28.28B in the quarter ending December 31, 2025, a decrease of -22.81%.
Revenue
140.19B
Revenue Growth
+8.56%
P/S Ratio
0.60
Revenue / Employee
1.56B
Employees
90
Market Cap
83.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 140.19B | 11.05B | 8.56% |
| Dec 31, 2024 | 129.14B | 33.59B | 35.15% |
| Dec 31, 2023 | 95.55B | -26.53B | -21.73% |
| Dec 31, 2022 | 122.09B | 22.17B | 22.19% |
| Dec 31, 2021 | 99.92B | 26.73B | 36.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Woowon Development | 376.35B |
| Creas F&C Co.,Ltd | 311.94B |
| Changhae Ethanol | 122.34B |
| Sinsin Pharmaceutical | 113.78B |
| TJ media | 94.43B |
| SDN Company. | 87.45B |
| HRS Co., Ltd | 78.91B |
| BBIA Co., Ltd. | 67.97B |